Umebronium bromide vilanterol inhalation powder should be Umebronium bromide vilanterol inhalation powder aerosol. The method of use is that it should be inhaled by mouth. Umebronium vilanterol inhalation powder should be inhaled orally, and the recommended dose for adults is 62.5 μg/25 μg of the product per inhalation (each inhalation contains 62.5 μg of umeclidinium bromide with 25 μg of vilanterol) once daily. The drug should be administered at the same time each day to maintain the bronchodilator effect. Umebronium Bromide Vilanterol Inhalation Powder Mist has a long-acting bronchodilator effect and is indicated for long-term maintenance therapy of chronic obstructive pulmonary disease. The drug is not indicated for use in children and adolescents. Adverse reactions in current clinical trials, include lower respiratory tract infection, neck pain, limb pain, back pain, chest pain, diarrhea, and cough. Umebronium Bromide Vilanterol Inhalation Powder Mist should be used in strict accordance with your doctor’s instructions and should not be used on your own.